Bone Extracellular Matrix (B-ECM) (B-ECM)

The bone extracellular matrix (ECM) is a complex, mineralized structure that serves as a mechanical scaffold and a significant reservoir for various growth factors and cytokines (Bussard et al., 2016). It is primarily composed of an inorganic phase of hydroxyapatite crystals and an organic phase dominated by type I collagen, which together provide structural integrity and sites for cellular attachment (Manolagas, 2000). This microenvironment sequesters essential signaling molecules such as transforming growth factor-beta (TGF-β), bone morphogenetic proteins (BMPs), and insulin-like growth factors (IGFs), which are released during the physiological process of bone remodeling (Wikesjö et al., 2008). In pathological conditions like bone metastasis, tumor cells exploit this reservoir by stimulating osteoclast activity, leading to the release of these growth factors which in turn promote tumor growth and further bone destruction—a process known as the "vicious cycle" (Paget, 1889; Mundy, 2002). Therapeutic interventions often target this scaffold directly; for instance, bisphosphonates bind to the hydroxyapatite component to inhibit resorption and stabilize the matrix (Russell, 2011). Additionally, the bone ECM is a focal point in regenerative medicine, where synthetic scaffolds are designed to mimic its reservoir function for the controlled release of osteoinductive factors to promote bone healing (Bose et al., 2012).

Other names

Bone matrixMineralized extracellular matrixBone microenvironmentHydroxyapatite-collagen scaffold

Bisphosphonates bind to hydroxyapatite crystals within the bone matrix, where they are internalized by osteoclasts during bone resorption, leading to osteoclast apoptosis and the preservation of the bone scaffold.